about
Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infectionToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesPeptides as targeting probes against tumor vasculature for diagnosis and drug deliveryTumorHoPe: a database of tumor homing peptidesPhysicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R.Novel target for peptide-based imaging and treatment of brain tumorsScreening of a combinatorial homing peptide library for selective cellular delivery.Bacteriophages and medical oncology: targeted gene therapy of cancer.Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system.Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.Phage Peptide Libraries As a Source of Targeted Ligands.Imaging key biomarkers of tumor angiogenesisA potential peptide vector that allows targeted delivery of a desired fusion protein into the human breast cancer cell line MDA-MB-231.Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.Cancer treatment using peptides: current therapies and future prospectsTargeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrierTargeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptideApplications of cell-penetrating peptides for tumor targeting and future cancer therapies.Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.Minimal killing unit of the mitochondrial targeting domain of Noxa.Next-generation nanoantibacterial tools developed from peptides.Molecular dynamics, thermodynamic, and mutational binding studies for tumor-specific LyP-1 in complex with p32.Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs.Computational approach for designing tumor homing peptides.Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid.Characterization of TCP-1 probes for molecular imaging of colon cancer.Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer.Silk Materials Functionalized via Genetic Engineering for Biomedical Applications.99m Tc-labeled NGR-chlorambucil conjugate, 99m Tc-HYNIC-CLB-c(NGR) for targeted chemotherapy and molecular imaging.Comparative evaluation of 68 Ga-labeled NODAGA, DOTAGA, and HBED-CC-conjugated cNGR peptide chelates as tumor-targeted molecular imaging probes.A modular and noncovalent transduction system for leucine-zipper-tagged proteins.Peptide-mediated vectorization of metal complexes: conjugation strategies and biomedical applications.Fast indirect fluorine-18 labeling of protein/peptide using the useful 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl prosthetic group: A method comparable to direct fluorination.Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning.Tumour-homing chimeric polypeptide-conjugated polypyrrole nanoparticles for imaging-guided synergistic photothermal and chemical therapy of cancer.Engineered Exosomes With Ischemic Myocardium-Targeting Peptide for Targeted Therapy in Myocardial Infarction
P2860
Q26822719-C11B5C7C-1B20-4FA3-94EB-376F48A4B0D5Q26995399-FFE3FF08-0C9B-4644-BAEA-3FF2FCFF036CQ27024850-609E8D2D-E1C8-40CD-A4A7-B5D0359FCB74Q28482352-27642FCF-6226-4864-9FC6-FB7C37ABB793Q30847079-00BB0BC3-A5B1-40CD-8C79-DBDEABB0925BQ33554409-2DFDF6CC-5DA5-404B-AD17-CA42200AB5D4Q33938342-3324B55E-8A04-4E9D-BF4D-ED5DD1E315CEQ35204972-B4A62EA2-00C4-4EB8-A75C-3EA4EC49B69FQ35676118-43726730-B384-489C-9689-C61A0B6976B4Q35783096-0541AB78-80A5-4A0B-B039-A6E14EE8620AQ35995567-A7AF277C-B4C7-4754-8379-D4F76B3AC293Q35999557-83F3D052-3668-45DB-8EA3-3925E23805BDQ36055183-066F21EC-A369-46B9-8018-A0B18BE831F1Q36176102-B9E8077B-D8BB-474E-A502-CA08FB34DEF4Q36515785-27E909DA-DFDC-4076-ACCB-1ABA01DCB4B1Q36525748-C8790B90-24B0-4FE4-9C2A-D57579C01201Q36550855-40E6E332-CDFD-46DD-AE86-BFA36FC699A2Q38166533-1E90114D-325E-49AD-8AB7-3A22F78D7FE4Q38364462-31E98A6F-AE03-4856-A631-AD81C0C0F9CBQ38449256-7B5B41EF-7036-4001-8F68-A2F8C115BEF4Q38501669-5FA88160-2C97-4008-BB33-4A41FA33E2A7Q38828282-EA283260-5928-4097-A212-5114FC697E0BQ39028900-FBF397F4-A2DC-4A07-BFB4-F990F4F8A4C9Q39166023-006355FA-81B0-4EBE-983E-87F82DF332D8Q39619566-FB7B4300-860B-4D0B-8956-52A72C46C30BQ39622438-291A3E1B-D194-4794-8592-EF9C4F5E6F59Q42045294-D4079BFD-18CB-4009-B6AE-8F6B159B06F0Q42226373-22F6E09B-AE13-4C66-8559-3C9DF812946FQ45299208-18EB0270-4838-4F59-9064-46A7621B7C01Q47095789-1A5796E5-6042-437F-B533-D87234A93A55Q48091368-712B4E78-C827-4A2A-AC8E-5EC31F07DC06Q48317907-692CF9DB-C599-4661-B837-4F465BF15CE5Q50239793-E067E6B0-8AB7-44C1-95A7-77FFFE6552DAQ50860069-84E3E754-A453-4AA4-A119-9D636D2D28AAQ51251756-BB4BFFA0-1557-49CE-BB41-59FEC34096C3Q53699625-D47CB55A-50A7-4215-8613-EF9AE110DF7FQ54969380-47BE4DAB-6CA6-4522-ACF3-35BAD5977D28Q55364407-673645D4-52EB-4A3E-A3DD-DE5AACA5B757Q58130049-25DAF02D-C360-4C65-AE02-85F124644512
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Homing peptides as targeted delivery vehicles.
@en
Homing peptides as targeted delivery vehicles.
@nl
type
label
Homing peptides as targeted delivery vehicles.
@en
Homing peptides as targeted delivery vehicles.
@nl
prefLabel
Homing peptides as targeted delivery vehicles.
@en
Homing peptides as targeted delivery vehicles.
@nl
P356
P1433
P1476
Homing peptides as targeted delivery vehicles
@en
P2093
Kirsi Vuorinen
P2860
P304
P356
10.1039/C0IB00013B
P577
2010-07-26T00:00:00Z